Back to Agenda
The Future of Healthcare is Digital, Genomic and Collaborative- Is the EU Policy and Regulatory Framework Ready? How Can Emerging Technologies Be Transforming?
Session Chair(s)
Armin Ritzhaupt, PhD, MPH
Scientific Administrator
European Medicines Agency, Netherlands
The future of innovative medicine development uses new approaches and technology providing transformative opportunities for patients yet challenging the current regulatory framework of medicine and devices. New ways of collaboration will be the key
Speaker(s)
Panelist
Christophe Lahorte
Federal Agency for Medicines and Health Products, Belgium
Head of National Innovation Office and Scientific-Technical Advice Unit
Panelist
Jessica G. Shull, PhD, MA, MS
Digital Therapeutics Alliance (DTA), Spain
European Lead
Panelist
Gilles Erb, DrMed, DrSc
F. Hoffmann-La Roche Ltd, Switzerland
Global scientific director in integrated molecular medicines team
Have an account?